English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Amanda Rupp | Aug 22, 2016

FDA moves forward with BASE inhibitor for Alzheimer’s patients

+ Technology/Innovation
Amanda Rupp | Aug 22, 2016

Surgery useful for treating myasthenia gravis

+ Technology/Innovation
Amanda Rupp | Aug 21, 2016

Protein target found for ALS

+ Regulatory
Amanda Rupp | Aug 21, 2016

Update released on state legislation to decrease cancer presence

+ Community
Amanda Rupp | Aug 21, 2016

NORD releases statement about PDUFA VI commitment letter

+ Community
Amanda Rupp | Aug 21, 2016

Epilepsy Foundation releases two medical grants

+ Technology/Innovation
Amanda Rupp | Aug 21, 2016

Study launched for HIV treatment

+ Technology/Innovation
Amanda Rupp | Aug 21, 2016

Oral immunotherapy proves useful for children with peanut allergies

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 437
  • 438
  • 439
  • 440
  • 441
  • 442
  • 443
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily